Tagged Articles

sumatriptan 3 articles

Teva discontinues sales of migraine patch due to reports of burns, scarring

Less than two weeks after the Food and Drug Administration (FDA) announced it had launched an investigation into reports of burns and potential permanent scarring  related to the Zecuity patch used to treat migraine headaches, the manufacturer, Teva Pharmaceuticals, announced it has decided to temporarily suspend sales, marketing and distribution to launch its own investigation into related safety risks. The FDA is informing health care professionals to discontinue prescribing Zecuity, and informing patients to stop using any remaining patches and contact their prescribers for an alternative migraine medicine. The Zecuity patch contains the active ingredient sumatriptan, a prescription medication used ... Read More

FDA approves first-ever migraine medicine skin patch

NuPathe is launching the first-ever patch to treat migraine headache, a product the device’s maker says is “game changing” to migraine sufferers. The Food and Drug Administration (FDA) gave NuPathe’s Zecuity the nod last week, and the company says it is currently focusing on securing commercial partners for the patch and hopes to have the patch on the market by the end of the year. Zecuity is a single-use, battery-powered patch that actively delivers the migraine medication sumatriptan through the skin. Sumatriptan has been on the market since 1991. It is administered in several forms including tablets, subcutaneous injection, and ... Read More

Aspirin plus Reglan shows promise as migraine treatment

A combination of aspirin and the anti-nausea medication metoclopramide, marketed as Reglan, may help patients with migraines find relief from headaches and vomiting within two hours, according to data from 13 clinical trials in which patients published in the Cochrane Database of Systematic Reviews. Patients in the clinical trials were randomly assigned to treat their migraines with either a single dose of 900 to 1,000 milligrams of aspirin, a placebo, or an active drug, usually the prescription migraine drug sumatriptan. Researchers found that 52 percent of aspirin users got at least some pain relief – or a reduction of pain ... Read More